Betamethadol

Betamethadol
Systematic (IUPAC) name
(3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanol
Clinical data
Identifiers
17199-55-2
None
PubChem CID 10064061
ChemSpider 8239601
ChEMBL CHEMBL162243
Chemical data
Formula C21H29NO
311.461 g/mol

Betamethadol (INN), or β-methadol, also known as betametadol, is a synthetic opioid analgesic.[1] It is an isomer of dimepheptanol (methadol), the other being alphamethadol (α-methadol).[2] Betamethadol is composed of two isomers itself, L-β-methadol, and D-β-methadol.[2] Based on structure-activity relationships it can be inferred that both isomers are likely to be active as opioid analgesics, similarly to those of betacetylmethadol (β-acetylmethadol).[3]

Betamethadol is a Schedule I controlled substance in the United States and has a DEA ACSCN of 9609 and an annual aggregate manufacturing quota of 2 grammes.

See also

References

  1. F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1294. ISBN 978-0-412-46630-4. Retrieved 15 May 2012.
  2. 2.0 2.1 United Nations Office on Drugs and Crime (2006). Dictionnaire Multilingue Des Stupéfiants Et Des Substances Psychotropes Placés Sous Contrôle International. United Nations Publications. p. 103. ISBN 978-92-1-048117-5. Retrieved 15 May 2012.
  3. Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424.